Distribution of risk factors and prophylactic drug usage in Turkish patients with angiographically established coronary artery disease

Basit Öğe Kaydı
dc.contributor.authorSönmez, Kenan
dc.contributor.authorAkçay, Ahmet
dc.contributor.authorAkçakoyun, Mustafa
dc.contributor.authorDemir, Durmuş
dc.contributor.authorElönü, Orhan Hakan
dc.contributor.authorPala, Selçuk
dc.contributor.authorEkşi Duran, Nilüfer
dc.contributor.authorGençbay, Murat
dc.contributor.authorDeğertekin, Muzaffer
dc.contributor.authorTuran, Fikret
dc.date.accessioned2024-07-12T21:03:48Z
dc.date.available2024-07-12T21:03:48Z
dc.date.issued2002en_US
dc.departmentFakülteler, Tıp Fakültesien_US
dc.description.abstractBackground: Coronary artery disease (CAD) is the leading cause of adult deaths in our country. In clinical practice, an adequate level of secondary prevention towards CAD primarily requires full recognition of the distribution of risk factors. The aim of our study was to determine the prevalence of coronary risk factors and the use of prophylactic drugs among patients who have an angiographically proven CAD in our centre, and to compare it with those of the EUROASPIRE I and II studies. Design: Cross-sectional, observational study. Methods: Our patients comprise 617 subjects (516 male, mean age 57.2 +/- 10.8 years) who underwent an angiography between January 2000 and May 2000 for the first time and in whom significant coronary lesions were detected. Age, gender, family history of premature CAD (FH), diabetes mellitus (DM), hypertension (HT), lipid profile, smoking, body mass index, waist circumference, hip circumference and physical activity data were recorded prior to angiography. The medical treatments received by these cases at discharge from hospital were investigated. Data thus obtained were compared with the results of the EUROASPIRE I and II trials, which studied the frequency of existing risk factors and prophylactic drug use among CAD patients in European countries. Results: Hyperlipidaemia, FH, DM, HT, smoking, obesity, central obesity were found in 52, 26, 20, 41, 65, 18 and 29% of patients, respectively. The use of antiplatelets, beta-blockers, ACE inhibitors, statins and calcium antagonists were 99, 86, 40, 63 and 16%, respectively. Conclusion: Upon comparison of the risk factors, prevalence of obesity and DM was found to be similar to the average of nine European countries among our subjects. Smoking was found to be considerably higher, whereas HT, hyperlipidaemia and family history of premature CAD were lower than the European average within our subjects. In our cases the frequency of prophylactic drug usage at discharge was higher than the European means.en_US
dc.identifier.citationSönmez, K., Akçay, A., Akçakoyun, M., Demir, D., Elönü, O. H., Pala, S., Ekşi Duran, N., Gençbay, M., Değertekin, M. ve Turan, F. (2002). Distribution of risk factors and prophylactic drug usage in Turkish patients with angiographically established coronary artery disease. European Journal of Preventive Cardiology. 9(4), s. 199-205.en_US
dc.identifier.endpage205en_US
dc.identifier.issn2047-4881
dc.identifier.issue4en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage199en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12415/3699
dc.identifier.volume9en_US
dc.institutionauthorEkşi Duran, Nilüfer
dc.language.isoenen_US
dc.publisherSage Journalsen_US
dc.relation.ispartofEuropean Journal of Preventive Cardiologyen_US
dc.relation.isversionof10.1177/174182670200900404en_US
dc.relation.publicationcategoryUluslararası Hakemli Dergide Makale - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmzKY00883
dc.subjectCoronary artery diseaseen_US
dc.subjectRisk factorsen_US
dc.subjectTurkish patientsen_US
dc.titleDistribution of risk factors and prophylactic drug usage in Turkish patients with angiographically established coronary artery diseaseen_US
dc.typeArticle
dspace.entity.typePublication

Dosyalar

Koleksiyon

Tıp Fakültesi Koleksiyonu